Alessandra Maio
Biographic Data
| ID | 10009277 |
|---|---|
| NAME | Alessandra Maio |
| GIVEN NAMES | Alessandra |
| FAMILY NAME | Maio |
| SIGNATURE | MAIO A |
| AFFILIATIONS | Università Cattolica del Sacro Cuore |
| ORCID | 0009-0007-4663-2619 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
A multi-stakeholder perspective on barriers to the adoption of personalized prevention in European healthcare systems
Introduction Personalized prevention is an important component of personalized medicine, tailoring interventions to the biological, behavioral, sociocultural and environmental characteristics of individuals for the prevention of disease onset, progression and recurrence. Despite its potential, personalized preventive interventions (PPI) remain less commonly implemented in clinical practice. This study explored the main barriers to a broader adopt…
Scanning the horizon of personalized prevention research
Introduction: Non-communicable diseases represent a significant burden on global healthcare, necessitating innovative strategies to enhance prevention and management. Personalized prevention, an emerging approach leveraging omics data to tailor interventions, holds promise for improving risk stratification, early diagnosis, and preventive strategies. To gain insights on the latest funding investments in this field, we mapped European Commission (…
Efficacy of polygenic risk scores and digital technologies for Innovative personalized cardiovascular disease PREVention in high-risk adults
Background: Cardiovascular diseases (CVDs) pose a significant global health challenge, necessitating innovative approaches for primary prevention. Personalized prevention, based on genetic risk scores (PRS) and digital technologies, holds promise in revolutionizing CVD preventive strategies. However, the clinical efficacy of these interventions requires further investigation. This study presents the protocol of the INNOPREV randomized controlled …
No prominent works on this page.
Efficacy of polygenic risk scores and digital technologies for Innovative personalized cardiovascular disease PREVention in high-risk adults
Background: Cardiovascular diseases (CVDs) pose a significant global health challenge, necessitating innovative approaches for primary prevention. Personalized prevention, based on genetic risk scores (PRS) and digital technologies, holds promise in revolutionizing CVD preventive strategies. However, the clinical efficacy of these interventions requires further investigation. This study presents the protocol of the INNOPREV randomized controlled …
Scanning the horizon of personalized prevention research
Introduction: Non-communicable diseases represent a significant burden on global healthcare, necessitating innovative strategies to enhance prevention and management. Personalized prevention, an emerging approach leveraging omics data to tailor interventions, holds promise for improving risk stratification, early diagnosis, and preventive strategies. To gain insights on the latest funding investments in this field, we mapped European Commission (…
A multi-stakeholder perspective on barriers to the adoption of personalized prevention in European healthcare systems
Introduction Personalized prevention is an important component of personalized medicine, tailoring interventions to the biological, behavioral, sociocultural and environmental characteristics of individuals for the prevention of disease onset, progression and recurrence. Despite its potential, personalized preventive interventions (PPI) remain less commonly implemented in clinical practice. This study explored the main barriers to a broader adopt…
Nutrition, Genetics, and Disease (3 works) · BRCA gene mutations in cancer (2 works) · Computer Science (2 works) · Health care (2 works) · Medicine (2 works) · Psychological intervention (2 works) · Alternative medicine (1 work) · Bioinformatics (1 work) · Biology (1 work) · Cardiovascular Health and Risk Factors (1 work)